Biologics Have High Rate Of Safety Risks: Study
4 CommentsBy Ed Silverman // October 21st, 2008 // 10:37 am
• Pharma Blog » Archives
Erbitux
Lilly Agrees To Buy ImClone For $6.5 Billion
Make a commentBy Ed Silverman // October 6th, 2008 // 7:25 am
ImClone Receives Offer From Its Mystery Date
Make a commentBy Ed Silverman // October 1st, 2008 // 9:17 pm
ImClone To Pursue A Deal With Its Mystery Date
1 CommentBy Ed Silverman // September 29th, 2008 // 7:29 am
Bristol Begins Hostile ImClone Bid With Higher Price
Make a commentBy Ed Silverman // September 22nd, 2008 // 7:31 pm
Bristol-Myers May Walk Away From ImClone
Make a commentBy Ed Silverman // September 16th, 2008 // 9:27 am
Carl Icahn To Jim Cornelius: ‘I Don’t Understand’
2 CommentsBy Ed Silverman // September 12th, 2008 // 7:28 am
Bristol-Myers To Carl Icahn: Our Offer Is Firm
Make a commentBy Ed Silverman // September 11th, 2008 // 12:50 pm
ImClone Rejects Bristol But Has A Mysterious Suitor
5 CommentsBy Ed Silverman // September 10th, 2008 // 9:44 am